FDA appears to pause controversial speedy review program, complete response letter disclosures

The FDA has quietly shelved the Commissioner’s National Priority Voucher (CNPV) pilot program, Reuters reports. Meanwhile, the agency also appears to have paused publishing complete response letters after briefly halting—and then resuming—the practice in July.